Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Preleukemia × filanesib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 4 Leukemia, Plasma Cell 3 Plasmacytoma 2 Paraproteinemias 2 Preleukemia 1 Leukemia, Myeloid, Acute 1 Advanced Solid Tumors 1

Interventions

spartalizumab 1 sabatolimab 1 ruxolitinib 1 lintuzumab 1 filanesib 1 Stem Cell Transplantation 1 Sampling Studies 1 Melphalan 1 Lenalidomide 1 Decitabine 1 Clofarabine 1 CPI-0610 1 Azacitidine 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637052 2021-02-08

A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia

Pfizer

Phase 1/2 Completed

Other hematologic neoplasm

Preleukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡